文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

小剂量促肾上腺皮质激素试验在危重症患者中的预后价值

PROGNOSTIC VALUE OF LOW-DOSE ADRENOCORTICOTROPIC HORMONE TEST IN CRITICALLY ILL PATIENTS.
PubMed 文献 · Shock · 2023-04-04
一句话结论脓毒性休克患者中1 μg ACTH试验诊断CIRCI发生率为43.6%,CIRCI组中位生存更低、AKI发生更早,作者推荐用1 μg ACTH试验识别该亚组。

该前瞻性队列研究纳入39例脓毒性休克患者,用1 μg ACTH刺激试验定义CIRCI(Δmax皮质醇<9 μg/dL),CIRCI发生率为43.6%。CIRCI组与非CIRCI组在ICU评分、实验室检查、血管加压药、机械通气天数、每日液体量及ICU住院时间上无显著差异(P>0.05)。CIRCI组中位生存时间5天、生存概率48.4%,非CIRCI组为7天、49.5%;CIRCI组发生AKI时间更短(4天 vs 6天)、发生AKI概率更高(44.6% vs 45.57%)。作者结论为CIRCI组平均生存率更低、AKI发生率更高,推荐在脓毒性休克患者中使用1 μg ACTH试验识别该亚组。

要点

  • 脓毒性休克患者用1 μg ACTH刺激试验,CIRCI(Δmax皮质醇<9 μg/dL)发生率为43.6%。
  • CIRCI组中位生存5天、生存概率48.4%,非CIRCI组为7天、49.5%。
  • CIRCI组发生AKI时间4天、概率44.6%,非CIRCI组为6天、45.57%。
  • 两组ICU评分、实验室检查、血管加压药、机械通气天数、每日液体量及ICU住院时间无显著差异(P>0.05)。
  • 作者推荐在脓毒性休克患者中使用1 μg ACTH试验识别CIRCI亚组。

适用人群与场景

  • 39例脓毒性休克患者,前瞻性队列研究。

诊断标准与关键阈值

  • CIRCI定义:1 μg ACTH刺激试验后Δmax皮质醇<9 μg/dL。

研究设计与关键结果

  • 研究类型:前瞻性队列研究,样本量39例脓毒性休克患者。
  • 主要终点为死亡;次要终点包括血管加压药天数、机械通气天数、每日液体量、AKI发生率及ICU住院天数。
  • 1 μg ACTH试验下CIRCI发生率为43.6%。
  • CIRCI组与非CIRCI组在ICU评分、实验室检查、血管加压药、机械通气天数、每日液体量及ICU住院时间上无显著差异(P>0.05)。
  • CIRCI组中位生存5天、生存概率48.4%,非CIRCI组中位生存7天、生存概率49.5%。
  • CIRCI组发生AKI时间4天、发生AKI概率44.6%,非CIRCI组发生AKI时间6天、概率45.57%。

证据类型、等级与局限

  • 证据类型:前瞻性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者推荐在脓毒性休克患者中使用1 μg ACTH试验识别CIRCI亚组。
  • 作者认为CIRCI组平均生存率更低、AKI发生率更高。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: Previous trials evaluated the incidence of critical illness-related corticosteroid insufficiency (CIRCI) using 250 μg adrenocorticotropic hormone (ACTH). However, this supraphysiological dose could result in false-positive levels. We aimed to determine the incidence of CIRCI in septic patients using a 1 μg ACTH stress test. Methods: We conducted a prospective cohort study on 39 patients with septic shock. Critical illness-related corticosteroid insufficiency was defined as a Δ max cortisol <9 μg/dL after 1 μg ACTH stress test. The primary outcome of the study was death. Secondary outcomes included days of vasopressors, days of mechanical ventilation (MV), amount of fluid per day, the incidence of acute kidney injury (AKI), and days of intensive care unit (ICU) stay. Results: The incidence of CIRCI in our cohort was 43.6% using 1 μg ACTH. There were no significant differences between groups in terms of ICU scores, laboratory investigations, vasopressors, MV days, amount of fluid per day, and the ICU stay ( P = > 0.05). The CIRCI group had lower median survival and survival probability rates (5 days and 48.4%, respectively) compared with the non-CIRCI group (7 days and 49.5%, respectively). In addition, the CIRCI group had a shorter time to develop AKI and a higher probability of developing AKI (4 days and 44.6%, respectively) in comparison with the non-CIRCI group (6 days and 45.57%, respectively). Conclusion: We concluded that the CIRCI group had a lower mean survival rate and a higher incidence of AKI. We recommend the use of 1 μg ACTH test in septic shock patients to identify this subgroup of patients.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Abdelrehim AB, Mohsen FM, Haredi MA, et al. PROGNOSTIC VALUE OF LOW-DOSE ADRENOCORTICOTROPIC HORMONE TEST IN CRITICALLY ILL PATIENTS. Shock. 2023. PMID: 37011042. doi:10.1097/SHK.0000000000002124

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。